← FDA DRUG APPROVALS

FDA ANDA · ANDA217276

EPHEDRINE SULFATE

Sponsor: ZYDUS PHARMS

APPLICATION
ANDA217276
TYPE
ANDA
ORIGINAL APPROVAL
2023-05-16
LATEST ACTION
2023-05-16
ROUTE
INTRAVENOUS
DOSAGE FORM
SOLUTION
MARKETING STATUS
Discontinued

Products

EPHEDRINE SULFATEDiscontinued
EPHEDRINE SULFATE 50MG/ML (50MG/ML) · SOLUTION · INTRAVENOUS

Approval history

2023-05-16UNKNOWN · Original · standardAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industryGMP disciplineFDA drug shortagesFDA enforcement & recalls

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →